BERNADETTE MAYERS: Open Payments
NPI 1265771406 · SOUTH OZONE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,473 in 20 payments from 10 companies in 2025. Trend: 2023 $1,377 · 2024 $1,822 · 2025 $2,473
Food & beverage: $2,473
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 | $620 |
| Otsuka America Pharmaceutical, Inc. | 3 | $425 |
| Neurocrine BioSciences, Inc. | 2 | $324 |
| Alkermes, Inc. | 2 | $250 |
| Teva Pharmaceuticals USA, Inc. | 3 | $215 |
| Abbott Laboratories | 1 | $138 |
| E.R. Squibb & Sons, L.L.C. | 1 | $126 |
| ABIOMED | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
Products named: INGREZZA, REXULTI, LYBALVI, UZEDY, ABILIFY MAINTENA, FREESTYLE LIBRE 3, COBENFY, Vemlidy.
Industry payments across NY — which companies pay providers there.
